These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9016322)

  • 1. Rationally designed inhibitors of inosine monophosphate dehydrogenase.
    Zhang HZ; Rao K; Carr SF; Papp E; Straub K; Wu JC; Fried J
    J Med Chem; 1997 Jan; 40(1):4-8. PubMed ID: 9016322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potent "fat base" nucleotide inhibitor of IMP dehydrogenase.
    Wang W; Hedstrom L
    Biochemistry; 1998 Aug; 37(34):11949-52. PubMed ID: 9718319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid-base catalysis in the chemical mechanism of inosine monophosphate dehydrogenase.
    Markham GD; Bock CL; Schalk-Hihi C
    Biochemistry; 1999 Apr; 38(14):4433-40. PubMed ID: 10194364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter evaluation of a new inosine monophosphate dehydrogenase inhibition assay for quantification of total mycophenolic acid in plasma.
    Brandhorst G; Marquet P; Shaw LM; Liebisch G; Schmitz G; Coffing MJ; Domke I; Streit F; Luthe H; Oellerich M
    Ther Drug Monit; 2008 Aug; 30(4):428-33. PubMed ID: 18641549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors.
    Franchetti P; Cappellacci L; Pasqualini M; Petrelli R; Jayaprakasan V; Jayaram HN; Boyd DB; Jain MD; Grifantini M
    Bioorg Med Chem; 2005 Mar; 13(6):2045-53. PubMed ID: 15727858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic mechanism of human inosine 5'-monophosphate dehydrogenase type II: random addition of substrates and ordered release of products.
    Wang W; Hedstrom L
    Biochemistry; 1997 Jul; 36(28):8479-83. PubMed ID: 9214292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenebis(sulfonamide) linked nicotinamide adenine dinucleotide analogue as an inosine monophosphate dehydrogenase inhibitor.
    Chen L; Gao G; Bonnac L; Wilson DJ; Bennett EM; Jayaram HN; Pankiewicz KW
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3152-5. PubMed ID: 17395461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ribonucleoside-5'-monophosphates with disubstituted phosphate residue do not interact with human inosine monophosphate dehydrogenase].
    Shipitsyn AV; Shirokova EA
    Bioorg Khim; 1997 Jan; 23(1):42-5. PubMed ID: 9139642
    [No Abstract]   [Full Text] [Related]  

  • 9. Tritrichomonas foetus: a strategy for structure-based inhibitor design of a protozoan inosine-5'-monophosphate dehydrogenase.
    Luecke H; Prosise GL; Whitby FG
    Exp Parasitol; 1997 Nov; 87(3):203-11. PubMed ID: 9371085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery.
    Shu Q; Nair V
    Med Res Rev; 2008 Mar; 28(2):219-32. PubMed ID: 17480004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The practical synthesis of a methylenebisphosphonate analogue of benzamide adenine dinucleotide: inhibition of human inosine monophosphate dehydrogenase (type I and II).
    Pankiewicz KW; Lesiak K; Zatorski A; Goldstein BM; Carr SF; Sochacki M; Majumdar A; Seidman M; Watanabe KA
    J Med Chem; 1997 Apr; 40(8):1287-91. PubMed ID: 9111303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activities of 2-functionalized purine nucleosides.
    Nair V; Bera B; Kern ER
    Nucleosides Nucleotides Nucleic Acids; 2003 Feb; 22(2):115-27. PubMed ID: 12744599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD-analogues as potential anticancer agents: conformational restrictions as basis for selectivity.
    Pankiewicz KW; Zatorski A; Watanabe KA
    Acta Biochim Pol; 1996; 43(1):183-93. PubMed ID: 8790723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of 2-amino-1,3,4-thiadiazole (NSC 4728).
    Nelson JA; Rose LM; Bennett LL
    Cancer Res; 1977 Jan; 37(1):182-7. PubMed ID: 187332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors.
    Birch HL; Buckley GM; Davies N; Dyke HJ; Frost EJ; Gilbert PJ; Hannah DR; Haughan AF; Madigan MJ; Morgan T; Pitt WR; Ratcliffe AJ; Ray NC; Richard MD; Sharpe A; Taylor AJ; Whitworth JM; Williams SC
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5335-9. PubMed ID: 16202581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationships.
    Buckley GM; Davies N; Dyke HJ; Gilbert PJ; Hannah DR; Haughan AF; Hunt CA; Pitt WR; Profit RH; Ray NC; Richard MD; Sharpe A; Taylor AJ; Whitworth JM; Williams SC
    Bioorg Med Chem Lett; 2005 Feb; 15(3):751-4. PubMed ID: 15664851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory action of polyunsaturated fatty acids on IMP dehydrogenase.
    Mizushina Y; Dairaku I; Yanaka N; Takeuchi T; Ishimaru C; Sugawara F; Yoshida H; Kato N
    Biochimie; 2007 May; 89(5):581-90. PubMed ID: 17383068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
    Vethe NT; Bergan S
    Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric properties of inosine monophosphate dehydrogenase revealed through the thermodynamics of binding of inosine 5'-monophosphate and mycophenolic acid. Temperature dependent heat capacity of binding as a signature of ligand-coupled conformational equilibria.
    Bruzzese FJ; Connelly PR
    Biochemistry; 1997 Aug; 36(34):10428-38. PubMed ID: 9265623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor.
    Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.